The biobehavioral and neuroimmune impact of low-dose ionizing radiation

Brain, Behavior, and Immunity

Volumn 26, Issue 2, 2012, Pages 218-227

  York, Jason M ^a   Blevins, Neil A ^a   Meling, Daryl D ^a   Peterlin, Molly B ^b   Gridley, Daila S ^c   Cengel, Keith A ^b   Freund, Gregory G ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute radiation syndrome (ARS); Co; Cs; Innate immunity; Interleukin 1 (IL 1); Prodromal stage

Indexed keywords

ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSKELETON; FATIGUE; GAMMA RADIATION; GENETIC TRANSCRIPTION; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNE RESPONSE; INHIBITION KINETICS; IONIZING RADIATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTON RADIATION; RADIATION DOSE; RADIATION EXPOSURE; SOCIAL BEHAVIOR; UPREGULATION; WHOLE BODY RADIATION;

ANIMALS; CEREBRAL CORTEX; CYTOSKELETAL PROTEINS; DOSE-RESPONSE RELATIONSHIP, RADIATION; EXPLORATORY BEHAVIOR; FATIGUE; GAMMA RAYS; HIPPOCAMPUS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MICE; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; NEUROIMMUNOMODULATION; RADIATION, IONIZING; RESTRAINT, PHYSICAL; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; WHOLE-BODY IRRADIATION;

EID: 84856000495     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2011.09.006     Document Type: Article

References (50)

1. Bogo V. Radiation: behavioral implications in space. Toxicology 1988, 49:299-307.
2. Bower J.E. Cancer-related fatigue: Links with inflammation in cancer patients and survivors. Brain Behav. Immun. 2007, 21:863-871.
3. Bower J.E., Ganz P.A., Tao M.L., Hu W., Belin T.R., Sepah S., Cole S., Aziz N. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin. Cancer Res. 2009, 15:5534-5540.
4. Buynitsky T., Mostofsky D.I. Restraint stress in biobehavioral research: recent developments. Neurosci. Biobehav. Rev. 2009, 33:1089-1098.
5. Capuron, L., Schroecksnadel, S., Féart, C. Aubert, A., Hiqueret, D., Barberger-Gateau, P., Layé, S., Fuchs, D., 2011. Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol. Psychiatry Epub ahead of print.
6. Cavadini G., Petrzilka S., Kohler P., Jud C., Tobler I., Birchler T., Fontana A. TNF-α suppresses the expression of clock genes by interfering with E-box-mediated transcription. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:12843-12848.
7. Cengel K.A., Diffenderfer E.S., Avery S., Kennedy A.R., McDonough J. Using electron beam radiation to simulate the dose distribution for whole body solar particle event proton exposure. Radiat. Environ. Biophys. 2010, 49:715-721.
8. Centers for Disease Control and Prevention, 2010. Acute radiation syndrome: A fact sheet for physicians. Retrieved September 23, 2010, from http://www.bt.cdc.gov/radiation/arsphysicianfactsheet.asp#2.
9. Centonze D., Muzio L., Rossi S., Furlan R., Bernardi G., Martino G. The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis. Cell Death Differ. 2010, 17:1083-1091.
10. Code of Federal Regulations, 1998 ed. Standards for Protection Against Radiation - Subpart C: Occupational Dose Limits. Title 10, Pt. 203.
11. Cucinotta F.A., Durante M. Cancer risk from exposure to galactic cosmic rays: implications for space exploration by human beings. Lancet Oncol. 2006, 7:431-435.
12. Dalen J.E. Economy class syndrome. Arch. Intern. Med. 2003, 163:2674-2676.
13. Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur. J. Pharmacol. 2004, 500:399-411.
14. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
15. Dantzer R., O'Connor J.C., Lawson M.A., Kelley K.W. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 2011, 36:426-436.
16. DeLano R.M., Mallery S.R. Stress-related modulation of central nervous system immunity in a murine model of herpes simplex encephalitis. J. Neuroimmunol. 1998, 89:51-58.
17. Donnelly E.H., Nemhauser J.B., Smith J.M., Kazzi Z.N., Farfán E.B., Chang A.S. Acute radiation syndrome: assessment and management. South Med. J. 2010, 103:541-544.
18. Evaluation Subcommittee of ASTRO's Emerging Technologies Committee, 2009. An evaluation of proton beam therapy. Retrieved from http://www.astro.org/HealthPolicy/EmergingTechnology/EvaluationProjects/documents/ProtonBeamReport.pdf.
19. Flint M.S., Tinkle S.S. C57BL/6 mice are resistant to acute restraint modulation of cutaneous hypersensitivity. Toxicol. Sci. 2001, 62:250-256.
20. Foley, J.F., 2007. Sleepy time with TNF-α. Sci. STKE 398, tw280.
21. Grajewski B., Waters M.A., Yong L.C., Tseng C., Zivkovich Z., Cassinelli R.T. Airline pilot cosmic radiation and circadian disruption exposure assessment from logbook and company records. Ann. Occup. Hyg. 2011, 55:465-475.
22. Hofman M., Ryan J.L., Figueroa-Moseley C.D., Jean-Pierre P., Morrow G.R. Cancer-related fatigue: the scale of the problem. Oncologist 2007, 12(Suppl 1):4-10.
23. James D.C. Radiation emergencies: a nurse can lead. J. Radiol. Nurs. 2006, 25:101-105.
24. Johnson D.R., O'Connor J.C., Hartman M.E., Tapping R.I., Freund G.G. Acute hypoxia activates the neuroimmune system, which diabetes exacerbates. J. Neurosci. 2007, 27:1161-1166.
25. Kim S., Thompson R.F. C-Fos, Arc and Stargazin expression in rat eyeblink conditioning. Behav. Neurosci. 2011, 125:117-123.
26. Lavin, D.N., Joesting, J.J., Chiu, G.S., Moon, M.L., Meng, J., Dilger, R.N., Freund, G.G., 2011. Fasting induces an anti-inflammatory effect on the neuroimmune system, which a high-fat diet prevents. Obesity Epub ahead of print.
27. Lawrence T.S., Ten Haken R.K., Giaccia A. Principles of Radiation Oncology Chapter 21. Cancer Principles & Practice of Oncology 2008, 307-336. Lippincott Williams & Wilkins, Philadelphia. V.T. DeVita, T.S. Lawrence, S.A. Rosenberg (Eds.).
28. Makhijani, A., 2011. Post-tsunami situation at the Fukushima Daiichi nuclear power plant in Japan: facts, analysis and some potential outcomes. Institute for Energy and Environmental Research release. 14-16 March 2011.
29. Maks C.J., Wan X.S., Ware J.H., Romero-Weaver A.L., Sanzari J.K., Wilson J.M., Rightnar S., Wroe A.J., Koss P., Gridley D.S., Slater J.M., Kennedy A.R. Analysis of white blood cell counts in mice after gamma- or proton-radiation exposure. Radiat. Res. 2011, 176(2):170-176.
30. Marquette C., Linard C., Galonnier M., Van Uye A., Mathieu J., Gourmelon P., Clarençon D. IL-1beta, TNF-alpha and IL-6 induction in the rat brain after partial-body irradiation: role of vagal afferents. Int. J. Radiat. Biol. 2003, 79:777-785.
31. Martinon F., Pétrilli V., Mayor A., Tardivel A., Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241.
32. Mikkelsen J.D., Larsen M.H. Effects of stress and adrenalectomy on activity-regulated cytoskeleton protein (Arc) gene expression. Neurosci. Lett. 2006, 403:239-243.
33. Mohler S.R. Galactic radiation exposure during commercial flights: is there a risk?. Can. Med. Assoc. J. 2003, 168:1157-1158.
34. Monroe A.T., Reddy S.C., Gibbs G.L., White G.A., Peddada A.V. Factors associated with radiation-induced nausea and vomiting in head and neck cancer patients treated with intensity modulated radiation therapy. Radiother. Oncol. 2008, 87:188-194.
35. Morphew M.E. Psychological and human factors in long duration space flight. McGill J. Med. 2001, 6:74-80.
36. Ni H., Balint K., Zhou Y., Gridley D.S., Maks C., Kennedy A.R., Weissman D. Effect of solar particle event radiation on gastrointestinal tract bacterial translocation and immune activation. Radiat. Res. 2011, 175:485-492.
37. Parsons J.L., Townsend L.W. Interplanetary crew dose rates for the August 1972 solar particle event. Radiat. Res. 2000, 153:729-733.
38. Patarca R. Cytokines and chronic fatigue syndrome. Ann. N.Y. Acad. Sci. 2001, 933:185-200.
39. Pecaut M.J., Haerich P., Zuccarelli C.N., Smith A.L., Zendejas E.D., Nelson G.A. Behavioral consequences of radiation exposure to simulated space radiation in the C57BL/6 mouse: open field, rotorod and acoustic startle. Cogn. Affect. Behav. Neurosci. 2002, 2:329-340.
40. Portenoy R.K., Itri L.M. Cancer-related fatigue: guidelines for evaluation and management. Oncologist 1999, 4:1-10.
41. Porter, R.S., Kaplan, J.L., 2006. The Merck Manual of Diagnosis and Therapy (18th ed., sec. 21, chap 317) Retrieved June 20, 2011, from http://www.merckmanuals.com/professional/sec21/ch317/ch317a.html.
42. Rosi S., Andres-Mach M., Fishman K.M., Levy W., Ferguson R.A., Fike J.R. Cranial irradiation alters the behaviorally induced immediate-early gene Arc (activity-regulated cytoskeleton-associated protein). Cancer Res. 2008, 68:9763-9770.
43. Schauer D.A., Linton O.W. National Council on Radiation Protection and Measurements report shows substantial medical exposure increase. Radiology (Oak Brook, IL, U. S.) 2009, 253:293-296.
44. Schroder K., Zhou R., Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger?. Science 2010, 327:296-300.
45. Sherry C.L., Kim S.S., Freund G.G. Accelerated recovery from acute hypoxia is due to obesity-associated up-regulation of Interleukin-1 receptor antagonist. Endocrinology 2009, 150:2660-2667.
46. Smith A.C., Dimulescu I., Falkenberg V.R., Narasimhan S., Heim C., Vernon S.D., Rajeevan M.S. Genetic evaluation of the serotonergic system in chronic fatigue syndrome. Psychoneuroendocrinology 2008, 33:188-197.
47. Soussain C., Ricard D., Fike J.R., Mazeron J., Psimanas D., Delattre J. CNS complications of radiotherapy and chemotherapy. Lancet 2009, 374:1639-1651.
48. Weissmann G. Fukushima Daiichi and Icarus: the human factor in a meltdown (Sv=1J/kgw). FASEB J. 2011, 25:1777-1780.
49. Xiao M., Whitnall M.H. Pharmacological countermeasures for the acute radiation syndrome. Curr. Mol. Pharmacol. 2009, 2:122-133.
50. Young R.W. Acute radiation syndrome. Military Radiobiology 1987, 166-186. Academic Press, New York. J.J. Conklin, R.I. Walker (Eds.).